Streetbeat News

Earnings

MTD

Mettler-Toledo has revised its 2023 local currency sales forecast, now expecting a decline of approximately 1%. Previously, the company had anticipated growth of 0%-1%.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:37 pm

LFVN

Lifevantage (NASDAQ:LFVN) reported Q1 earnings of $0.13 per share, a 116.67% increase YoY. However, sales were $51.36M, a 0.79% decrease from $51.77M YoY.

Portfolio Pulse from totan@benzinga.com

November 09, 2023 | 9:36 pm

HGBL

Heritage Glb (NASDAQ:HGBL) reported Q3 earnings of $0.05 per share, missing the analyst consensus estimate of $0.07 by 28.57%. This is a 16.67% decrease from the same period last year. However, the company reported quarterly sales of $15.55 million, beating the analyst consensus estimate of $13.38 million by 16.23%, a 22.83% increase from last year.

Portfolio Pulse from bharat@benzinga.com

November 09, 2023 | 9:36 pm

TCON

TRACON Pharmaceuticals reported its Q3 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:36 pm

ETON

Eton Pharmaceuticals (NASDAQ:ETON) reported its Q3 earnings results, beating estimated earnings by 80.0% with an EPS of $-0.02 versus an estimate of $-0.1. Revenue was up $3.81 million from the same period last year. Last quarter, the company beat on EPS by $0.27, which was followed by a 38.08% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:36 pm

NBY

NovaBay Pharmaceuticals (AMEX:NBY) reported its Q3 earnings, beating estimated earnings by 7.5% with an EPS of $-0.37 versus an estimate of $-0.4. However, revenue was down $561 thousand from the same period last year. Last quarter, the company missed on EPS by $0.72, which was followed by a 7.14% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:36 pm

OMER

Omeros Corporation (NASDAQ:OMER) reported its Q3 earnings, beating estimated earnings by 1.64% with an EPS of $-0.6 versus an estimate of $-0.61. However, revenue was down $0 from the same period last year. Last quarter, the company missed on EPS by $0.02, which was followed by a 3.0% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:35 pm

LCTX

Lineage Cell Therapeutics (AMEX:LCTX) reported Q3 earnings with an EPS of $-0.04, in line with estimates. However, revenue was down $1.75 million from the same period last year. Last quarter, the company beat EPS estimates, which led to a 2.13% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:35 pm

MTD

Mettler-Toledo Intl (NYSE:MTD) reported Q3 earnings, beating estimated earnings by 0.62% with an EPS of $9.8. However, revenue was down $43.39 million from the same period last year. Last quarter, the company also beat EPS estimates, which was followed by a 1.18% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:35 pm

GROV

Grove Collaborative Hldgs (NYSE:GROV) reported its Q3 earnings, missing estimated earnings by 106.67% with an EPS of $-0.31 versus an estimate of $-0.15. Revenue was down $15.98 million from the same period last year. Despite missing on EPS last quarter, the share price increased by 30.14% the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:35 pm